Results 1 to 10 of about 115,969,812 (153)

Lysosomal Enzyme Tripeptidyl Peptidase 1 Destabilizes Fibrillar Aβ by Multiple Endoproteolytic Cleavages Within the β-Sheet Domain [PDF]

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2018
Significance Alzheimer’s disease is the leading cause of dementia. Accumulation of amyloid-beta (Aβ) plaques, which include β-sheet fibrils of Aβ, is a hallmark of the disease. Aβ aggregates can be endocytosed by microglia and delivered to lysosomes, but degradation of fibrillar Aβ in microglial lysosomes is slow.
Ana V Rojas   +2 more
exaly   +5 more sources

Different molecular mechanisms involved in spontaneous and oxidative stress-induced mitochondrial fragmentation in tripeptidyl peptidase-1 (TPP-1)-deficient fibroblasts [PDF]

open access: yesBioscience Reports, 2013
NCLs (neuronal ceroid lipofuscinoses) form a group of eight inherited autosomal recessive diseases characterized by the intralysosomal accumulation of autofluorescent pigments, called ceroids.
Guillaume Van Beersel   +5 more
doaj   +7 more sources

Tripeptidyl Peptidase 1 (TPP1) Deficiency in a 36-Year-Old Patient with Cerebellar-Extrapyramidal Syndrome and Dilated Cardiomyopathy [PDF]

open access: yesLife, 2021
We report on a 36-year-old man with cerebellar-extrapyramidal syndrome and severe heart failure because of dilated cardiomyopathy of unknown origin. Dysarthria and cardiac arrhythmia began at early childhood (4 years of age).
Agnieszka Ługowska   +11 more
doaj   +4 more sources

A tripeptidyl peptidase 1 is a binding partner of the Golgi pH regulator (GPHR) in Dictyostelium [PDF]

open access: yesDisease Models & Mechanisms, 2017
Mutations in tripeptidyl peptidase 1 (TPP1) have been associated with late infantile neuronal ceroid lipofuscinosis (NCL), a neurodegenerative disorder. TPP1 is a lysosomal serine protease, which removes tripeptides from the N-terminus of proteins and is
Maria Stumpf   +8 more
doaj   +4 more sources

Inducible transgenic expression of tripeptidyl peptidase 1 in a mouse model of late-infantile neuronal ceroid lipofuscinosis. [PDF]

open access: yesPLoS ONE, 2018
Late-infantile neuronal ceroid lipofuscinosis is a fatal neurodegenerative disease of children caused by mutations resulting in loss of activity of the lysosomal protease, tripeptidyl peptidase 1 (TPP1).
Yuliya Nemtsova   +4 more
doaj   +5 more sources

Tripeptidyl Peptidase 1 Regulates Human Trophoblast Cell Proliferation Implying a Role in Placentation

open access: yesBioMed Research International, 2022
Proper placentation in the first trimester is essential for a healthy pregnancy in humans. A recent proteomics study of human placental tissue has identified that tripeptidyl peptidase 1 (TPP1) production is reduced in the placenta in early‐onset ...
Wei Zhou, E. Dimitriadis
semanticscholar   +5 more sources

Upregulation of tripeptidyl-peptidase 1 by 3-hydroxy-(2,2)-dimethyl butyrate, a brain endogenous ligand of PPARα: Implications for late-infantile Batten disease therapy

open access: yesNeurobiology of Disease, 2019
The late-infantile Batten disease or late-infantile neuronal ceroid lipofuscinosis (LINCL) is an autosomal recessive lysosomal storage disorder caused by mutations in the Cln2 gene leading to deficiency of lysosomal enzyme tripeptidyl peptidase 1 (TPP1).
Sudipta Chakrabarti   +5 more
doaj   +5 more sources

First in man study of intravitreal tripeptidyl peptidase 1 for CLN2 retinopathy

open access: yesEye, 2023
CLN2 Batten Disease is a fatal neurodegenerative condition of childhood associated with retinal dystrophy and blindness. Intracerebroventricular infusion of rhTPP1 greatly slows the rate of neurodegenerative decline but not retinopathy.
James Wawrzynski   +11 more
semanticscholar   +4 more sources

Elevated levels of tripeptidyl peptidase 1 do not ameliorate pathogenesis in a mouse model of Alzheimer disease

open access: yesNeurobiology of Aging, 2022
One potential therapeutic strategy for Alzheimer disease (AD) is to promote degradation of amyloid beta (Aβ) and we previously demonstrated that the lysosomal protease tripeptidyl peptidase 1 (TPP1) can degrade Aβ fibrils in vitro.
D. Sleat   +9 more
semanticscholar   +3 more sources

Compound heterozygous mutations in tripeptidyl peptidase 1 cause rare autosomal recessive spinocerebellar ataxia type 7: A case report

open access: yesWorld Journal of Clinical Cases, 2023
BACKGROUND Spinocerebellar ataxia recessive type 7 (SCAR7) is a rare clinical manifestation beginning in childhood or adolescence. SCAR7 is caused by tripeptidyl peptidase 1 (TPP1) gene mutations, and presents with cerebellar ataxia, pyramidal signs ...
R. Liu   +7 more
semanticscholar   +3 more sources

Home - About - Disclaimer - Privacy